您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > hMAO-B/MB-COMT-IN-1
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
hMAO-B/MB-COMT-IN-1
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
hMAO-B/MB-COMT-IN-1图片
包装与价格:
包装价格(元)
100mg电议
250mg电议
500mg电议

产品介绍
hMAO-B/MB-COMT-IN-1 是一种双重的MAO-B/MB-COMT抑制剂 (IC50s: hMAO-B 为 2.5 μM,MB-COMT 为 3.84 μM)。hMAO-B/MB-COMT-IN-1 可保护细胞免受氧化损伤。hMAO-B/MB-COMT-IN-1 可用于帕金森病 (PD) 等神经退行性疾病的研究。
生物活性

hMAO-B/MB-COMT-IN-1 is a dualMAO-B/MB-COMTinhibitor (IC50s: 2.5 μΜ for hMAO-B, 3.84 μΜ for MB-COMT). hMAO-B/MB-COMT-IN-1 protects cells against oxidative damage. hMAO-B/MB-COMT-IN-1 can be used in the research of neurodegeneration disease, such as Parkinson’s Disease (PD)[1].

IC50& Target

hMAO-B, MB-COMT[1]

体外研究
(In Vitro)

hMAO-B/MB-COMT-IN-1 (compound 3, 50 μM, 24 h) decreases in resazurin reduction in differentiated SH-SY5Y cells[1].
hMAO-B/MB-COMT-IN-1 (50 μM, 24 h) displays lysosomal toxicity by producing ROS in differentiated SH-SY5Y cells[1].
hMAO-B/MB-COMT-IN-1 (10 μM, 30 min) displays remarkable cytoprotective effects against t-BHP in differentiated SH-SY5Y cells[1].
hMAO-B/MB-COMT-IN-1 is predicted to cross the blood-brain barrier (BBB) by passive diffusion, determined by the parallel artificial membrane permeability assay (PAMPA)-BBB kit[1].

分子量

273.33

Formula

C16H19NO3

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.